down arrow

Novartis India

40
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
788.00
6.05 (0.77%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 14.33 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is -11.53% vs -5.28% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 0.28% vs 140.06% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is -14.86% vs -63.77% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is -17.58% vs 2,878.49% in Mar 2023

Compare Profit and Loss Results of Novartis India
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
335.00
9,264.00
-8,929.00
-96.38%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
335.00
9,264.00
-8,929.00
-96.38%
Expenditure (Ex Depriciation)
Stock Adjustments
9.00
-25.00
34.00
136.00%
Raw Materials Consumed
189.00
2,933.00
-2,744.00
-93.56%
Power & Fuel Cost
0.00
70.00
-70.00
-100.00%
Employee Cost
22.00
1,982.00
-1,960.00
-98.89%
Operating Expenses
5.00
143.00
-138.00
-96.50%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
15.00
806.00
-791.00
-98.14%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
8.00
136.00
-128.00
-94.12%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
269.00
6,939.00
-6,670.00
-96.12%
Operating Profit (PBDIT) excl Other Income
65.00
2,325.00
-2,260.00
-97.20%
Other Income
61.00
266.00
-205.00
-77.07%
Operating Profit (PBDIT)
126.00
2,592.00
-2,466.00
-95.14%
Interest
1.00
15.00
-14.00
-93.33%
Profit before Depriciation and Tax
125.00
2,577.00
-2,452.00
-95.15%
Depreciation
2.00
317.00
-315.00
-99.37%
Profit Before Taxation & Exceptional Items
122.00
2,259.00
-2,137.00
-94.60%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
122.00
2,259.00
-2,137.00
-94.60%
Provision for Tax
37.00
436.00
-399.00
-91.51%
Profit After Tax
85.00
1,823.00
-1,738.00
-95.34%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
759.00
7,868.00
-7,109.00
-90.35%
Profit Available for appropriations
844.00
9,691.00
-8,847.00
-91.29%
Appropriations
844.00
9,691.00
-8,847.00
-91.29%
Equity Dividend (%)
500%
0%
500.00
Earnings Per Share
34.5
45.52
-11.02
-24.21%
Profit And Loss - Net Sales
Net Sales 335.07 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -11.53% vs -5.28% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 65.26 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 0.28% vs 140.06% in Mar 2023

Profit And Loss - Interest
Interest 1.49 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -14.86% vs -63.77% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 85.19 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -17.58% vs 2,878.49% in Mar 2023